Anti-Kickback Statute
US federal criminal ban on paying for referrals in Medicare and Medicaid cases
The Anti-Kickback Statute is a US federal criminal provision — codified at 42 U.S.C. § 1320a-7b(b) — that prohibits any person from offering, paying, soliciting or receiving remuneration in order to induce or reward referrals, purchases or prescriptions of services, goods or treatments financed in whole or in part by federal health care programs such as Medicare and Medicaid.
The concept of 'remuneration' is interpreted broadly in US law and covers not only direct cash payments, but also gifts, discounts, commissions, free services and any other form of economic benefit. What matters is not the form of the payment but its purpose: if the payment is designed to influence a health care professional's decision to refer patients or prescribe particular products, it is potentially criminal.
For a violation to be prosecuted criminally, the act must have been committed 'knowingly and willfully' — that is, the perpetrator must have acted deliberately and intentionally in breach of the law. This intent requirement distinguishes the Anti-Kickback Statute from purely civil rules on breach of obligations and places it clearly as a criminal provision with serious sanctions available, including imprisonment for up to ten years and fines per violation.
The statute is administered and enforced primarily by the U.S. Department of Justice (DOJ) and the Office of Inspector General within the Department of Health and Human Services (HHS OIG). Violations may additionally trigger exclusion from participation in federal health care programs, which in practice can be devastating for a company's business model.
In a true crime context, the Anti-Kickback Statute is central to cases involving corruption in the pharmaceutical and health care industries. A prominent example is Purdue Pharma, which in 2020 admitted criminal liability for, among other things, paying doctors and health care personnel to prescribe the company's opioid products — payments that prosecutors characterised as unlawful kickbacks in breach of this very provision. The case illustrates how the Anti-Kickback Statute is used as a central legal instrument against systematic corruption that undermines the integrity of the American health care system.
